Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreEditor’s Note Introduction of new NEDC body image fact sheet Associate Professor Rachel F.
Read moreNEDC e-Bulletin Issue 36: The National Eating Disorders Collaboration of 2015 December is always a time to reflect and recap on the year’s activities and outcomes as we all prepare for a break and recuperation ahead of the New Year.
Read more